A HEALTHY POST-COVID MALE DEVELOPS CARDIOGENIC SHOCK SECONDARY TO VIRAL CARDIOMYOPATHY

Levosimendan: the inotrope of choice in cardiogenic shock secondary to takotsubo cardiomyopathy?

Takotsubo cardiomyopathy (TC) has become an increasingly recognised entity in Western literature since its initial reporting in Japan. The pathogenesis underlying the myocardial stunning and systolic dysfunction is thought to be induced by elevated systemic levels of catecholamines and neuropeptides. Whilst the majority of patients are haemodynamically stable, a small proportion can develop car...

Biventricular Stress-induced Cardiomyopathy and Cardiogenic Shock Secondary to Rheumatoid Arthritis Flare

Stress-induced cardiomyopathy has a wide variety of clinical presentations ranging from angina symptoms to cardiogenic shock, as well as an array of echocardiographic findings and etiologies. We present a unique case of severe biventricular dilation with cardiogenic shock but rapid recovery within 96 hrs. Severe biventricular stressinduced cardiomyopathy secondary to acute rheumatoid arthritis ...

Cardiogenic shock secondary to metamizole-induced type II Kounis syndrome.

No further incidents have been documented during patient follow-up. In the cases presented, the mechanism underlying the induction of ventricular fibrillation could have been due to the continuous transmission—through the ventricular electrode to the interface with the myocardium—of the electrocautery radiofrequency pulses applied to the surrounding tissue or the pacemaker generator itself, alt...

Cardiogenic shock.

The syndrome of cardiogenic shock (CS) comprises a constellation of symptoms and signs that define a subset of patients with inadequate tissue perfusion secondary to myocardial dysfunction. Careful attention to and rapid identification of patients at risk for the development of CS and those with impending CS by both hospitalists and subspecialists will help to implement the time-sensitive thera...

Cardiogenic Shock